A group of Canadian researchers published a study Wednesday highlighting a previously unknown link between certain amino acids and rare blood clots in AstraZeneca COVID-19 vaccine recipients.
Researchers said it could assist doctors in identifying and treating the blood clots which result from an immune-driven mix of coagulation and loss of platelets that stop bleeding, the Wall Street Journal reported. A team of researchers at McMaster University in Ontario published the findings in the Nature scientific journal, which builds on recent research in Europe about blood clots associated with the vaccine, and some scientists call vaccine-induced immune thrombotic thrombocytopenia (VITT).
The Daily Caller was founded in 2010 by Tucker Carlson, a 20-year veteran journalist, and Neil Patel, former chief policy advisor to Vice President Cheney, The Daily Caller is one of America’s largest and fastest-growing news publications. Our team of experienced, full-time reporters and editors works around the clock to deliver award-winning original reporting, in-depth investigations, entertainment, thought-provoking commentary and up-to-the-second breaking news. Visit https://dailycaller.com